1. Adriamycin. A new anticancer drug with significant clinical activity;Blum;Ann. Intern. Med.,1974
2. Prevention of doxorubicin-induced myocardial and haematological toxicities in rats by the iron chelator desferrioxamine;Al-Harbi;Cancer Chemother. Pharmacol.,1992
3. Protective effect of aminoguanidine against cardiovascular toxicity of chronic doxorubicin treatment in rats;Mostafa;Res. Commun. Mol. Pathol. Pharmacol.,1999
4. Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity;Al-Shabanah;J. Exp. Clin. Cancer Res.,1998
5. Captopril ameliorates myocardial and hematological toxicities induced by adriamycin;Al-Shabanah;Biochem. Mol. Biol. Int.,1998